Skip to content

The efficacy of Tadalafil in treatment of Methadone induced sexual dysfunction

The efficacy of Tadalafil in treatment of Methadone induced sexual dysfunction in males under methadone maintenance therapy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150822023705N10
Enrollment
130
Registered
2018-09-05
Start date
2018-10-23
Completion date
Unknown
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sexual dysfunction. Sexual dysfunction, not caused by organic disorder or disease

Interventions

Intervention 1: Intervention group: The group will receive Tadalafil treatment in one month. Daily drug intake will be one pill that will receive a pill of 10 mg in the first two week and a 20 mg pill

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Gender Male Patients under methadone treatment Minimum elementary education married ?Age between 20-50 years Diagnosis of Methadone induced sexual dysfunction by Psychiatrist Have not sexual problems before treatment with methadone No history of any glands disease, such as elevated prolactin and thyroid disorder willing and able to comply with the study conditions; Written informed consent

Exclusion criteria

Exclusion criteria: Gender female single changes in sexual activity because of wife pregnancy, remarried, divorce

Design outcomes

Primary

MeasureTime frame
Sexual dysfunction. Timepoint: The beginning of the study (baseline), week two and end of the study (week four). Method of measurement: Based on questionnaire Brief Sexual Function Inventory (BSFI) and International Index of Erectile Function (IIEF).;Sexual hormones level. Timepoint: The baseline and end of the study (four week). Method of measurement: By experimental Kit.

Secondary

MeasureTime frame
Level of the Thyroid hormone. Timepoint: The baseline of the study. Method of measurement: By experimental Kit.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Kakeri

Kermanshah University of Medical Sciences

faribakakeri@yahoo.com+98 83 3826 4513

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026